ZP
RYTM icon

Zimmer Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Zimmer Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,800
Closed -$2.84M – 153
2023
Q4 		$2.84M Sell
61,800
-20,700
-25% -$653K 0.1% 77
2023
Q3 		$1.89M Buy
+82,500
New +$1.85M 0.05% 102
2018
Q1 		– Sell
-35,000
Closed -$1.02M – 93
2017
Q4 		$1.02M Buy
+35,000
New +$926K 0.02% 74

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Zimmer Partners's RYTM Position: Q1 2024 in Review

Zimmer Partners sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2024, closing a stake of 61,800 shares — an estimated $2.84M sold.

Zimmer Partners first reported a position in RYTM in Q4 2017 and held it in 3 quarters. The position peaked at $2.84M in Q4 2023. 167 funds tracked by Wall St. Rank hold RYTM as of Q1 2024.

  • Zimmer Partners reported no remaining Rhythm Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Zimmer Partners sold 61,800 Rhythm Pharmaceuticals shares in Q1 2024, an estimated $2.84M.
  • Zimmer Partners first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Zimmer Partners's Rhythm Pharmaceuticals position peaked at $2.84M in Q4 2023.
  • 167 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2024.

Based on Zimmer Partners's 13F filing for Q1 2024, filed 15 May 2024.